International policy failures: cloning and stem-cell research

Tauer, Carol A.

doi:10.1016/s0140-6736(04)16637-3

Cited by 17 publications

(9 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Consider, for example, the role of a leading bioethicist in shaping the health policy views of the US federal administration (Ezekiel Emanuel) 7. Also, more and more health decisions have been seen in a bioethical light (eg, how to make coverage decisions regarding costly medical treatments8–10), while bioethics issues have moved from the bedside or research laboratory to the policy setting (eg, stem cell funding,11 12 healthcare rationing) 13 14. This is not a new phenomenon: years ago ‘bioethics’-like enquiries considered how best to ethically distribute organs 15.…”

Section: Engaging In the Public Squarementioning

confidence: 99%

Bioethics in the public square: reflections on thehow

Campbell

2012

J Med Ethics

View full text Add to dashboard Cite

As bioethics gains more prominence in public policy debates, it is time to more fully reflect on the following: what is its role in the public square, and what limitations relate to and barriers impede its fulfilment of this role? I contend we should consider the how of bioethics (as a policy influencer) rather than simply focus on the who or what of bioethical enquiry. This is not to suggest considerations of latter categories are not important, only that too little attention has been paid to parallel or resulting policy involvement-involvement that will require specialised skills and knowledge that we can develop with a proactive (vs reactive) stance. Moreover, and equally critically, this how of public policy involvement will require more transparency regarding influences (eg, philosophical, ideological, cultural, socio-political) on what bioethicists bring to the table and what constituency base each represents-a humility as to the scope of one's role. In this vision, bioethics is not one single person or belief system for a policymaker to call to guide or give support to a position; rather, it offers tools-formed and utilised by a diverse disciplinary range of individuals-to help guide ethical analysis of biomedical endeavours, with the goal of infusion and diffusion of ethical enquiry and prioritisation in health policymaking, and greater humility among bioethicists who inform this discussion.

show abstract

Section: Engaging In the Public Squarementioning

confidence: 99%

Bioethics in the public square: reflections on thehow

Campbell

2012

J Med Ethics

View full text Add to dashboard Cite

show abstract

“…Balancing women's autonomy and legal rights in constitutional democracies, and in some cases just women's physical access to participation in the ova trade, the UK, Canada, Germany and others have enacted legislation that establishes a responsible regulatory mechanism to oversee the market trade in young women's ovum. Importantly, some of the legislation attempts to transfer the burden of proof regarding safety on to the fertility and biotech industries (Tauer 2004;Washenfelder 2002). The global ova trade presents a daunting governance challenge.…”

Section: Andmentioning

confidence: 99%

Gender and Justice in the Gene Age: The Challenges Presented by Reproductive and Genetic Biotechnologies

Darling

2008

Women in Biotechnology

View full text Add to dashboard Cite

This chapter examines some of the challenges created by the rapid emergence, and in some prosperous nations, unregulated development of new reproductive and genetic biotechnologies and biomedical protocols that use and impact women's reproductive capacity. It also reports on the ova trade in the United States, and attempts at enforceable regulatory oversight of reproductive biotechnologies and egg donation in the US. Lastly, this article considers the social justice challenges posed by some emerging biomedical technologies in the context of distributive justice issues like women's bodily integrity and 'red biotechnologies', intergenerational justice, existing health equity resource sharing, and the longstanding challenge to the women's movement to support reproductive justice for marginalized women.

show abstract

“…Con relación a los aspectos legales la situación es a todas luces dispar. Mientras en algunos países existen leyes específicas que permiten la investigación con células estaminales embrionarias, en otros se prohíbe el uso de embriones humanos para la obtención de células estaminales, pero se permite la importación de dichas células en ciertos casos que no se especifican claramente, o se prohíbe en toda circunstancia la investigación con células estaminales embrionarias o simplemente no se tiene legislación específica 35 .…”

Section: A R T í C U L O E S P E C I a Lunclassified

Consideraciones científicas y éticas en las perspectivas diagnósticas y terapéuticas en medicina fetal

Soto-Chacón

2008

Rev. méd. Chile

View full text Add to dashboard Cite

Scientific and ethical perspectives of perinatal and fetal medicine This review emphasizes the importance of recent developments and knowledge on cell biology and human genetics than have integrated, through a basic-clinical concept, to an emerging branch of medicine, called Perinatal and Fetal Medicine. We discuss the possible role of fetal cells and DNA in the diagnosis and treatment of diseases in the intrauterine environment. The associated bioethical issues associated to these medical actions are discussed, considering the imminent use of these agents in the human species (

show abstract

International policy failures: cloning and stem-cell research

Cited by 17 publications

References 7 publications

Bioethics in the public square: reflections on thehow

Bioethics in the public square: reflections on thehow

Gender and Justice in the Gene Age: The Challenges Presented by Reproductive and Genetic Biotechnologies

Consideraciones científicas y éticas en las perspectivas diagnósticas y terapéuticas en medicina fetal

Contact Info

Product

Resources

About